Glory Health Industry Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zhangsun Zhang

Algemeen directeur

CN¥3.0m

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	no data
Eigendom CEO	76.7%
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Analyse CEO-vergoeding

Hoe is Zhangsun Zhang's beloning veranderd ten opzichte van Glory Health Industry's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-CN¥356m
Mar 31 2024	n/a	n/a	-CN¥460m
Dec 31 2023	CN¥3m	CN¥3m	-CN¥564m
Sep 30 2023	n/a	n/a	-CN¥531m
Jun 30 2023	n/a	n/a	-CN¥497m
Mar 31 2023	n/a	n/a	-CN¥705m
Dec 31 2022	CN¥3m	CN¥3m	-CN¥913m
Sep 30 2022	n/a	n/a	-CN¥817m
Jun 30 2022	n/a	n/a	-CN¥721m
Mar 31 2022	n/a	n/a	-CN¥246m
Dec 31 2021	CN¥3m	CN¥3m	CN¥228m
Sep 30 2021	n/a	n/a	CN¥261m
Jun 30 2021	n/a	n/a	CN¥294m
Mar 31 2021	n/a	n/a	CN¥196m
Dec 31 2020	CN¥3m	CN¥3m	CN¥99m
Sep 30 2020	n/a	n/a	CN¥301m
Jun 30 2020	n/a	n/a	CN¥502m
Mar 31 2020	n/a	n/a	CN¥681m
Dec 31 2019	CN¥3m	CN¥3m	CN¥860m
Sep 30 2019	n/a	n/a	CN¥943m
Jun 30 2019	n/a	n/a	CN¥1b
Mar 31 2019	n/a	n/a	CN¥1b
Dec 31 2018	CN¥3m	CN¥3m	CN¥1b
Sep 30 2018	n/a	n/a	CN¥1b
Jun 30 2018	n/a	n/a	CN¥2b
Mar 31 2018	n/a	n/a	CN¥2b
Dec 31 2017	CN¥3m	CN¥3m	CN¥2b

Compensatie versus markt: De totale vergoeding ($USD 422.36K ) Zhangsun } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 235.95K ).

Compensatie versus inkomsten: De vergoeding van Zhangsun is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Zhangsun Zhang (67 yo)

no data

Tenure

CN¥3,000,000

Compensatie

Mr. Zhangsun Zhang is the Founder of Glory Health Industry Limited (formerly known as Guorui Properties Limited). Mr. Zhang also serves as Chairman and President of Glory Health Industry Limited (formerly...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Zhangsun Zhang	Chairman & President	no data	CN¥3.00m	76.71% HK$ 416.0m
Xueer Donghas	Chief Financial Officer	no data	geen gegevens	geen gegevens
Wenjuan Ruan	VP & Executive Director	no data	CN¥2.27m	geen gegevens
Zhenhe Hao	VP & Executive Director	3yrs	CN¥240.00k	geen gegevens
Bin Li	Executive President	no data	geen gegevens	geen gegevens
Yuhong Zhao	GM of the Operation & HR Mgmt Center	no data	geen gegevens	geen gegevens
Zhang Chengjuan	Vice Director of the Legal Compliance Department	no data	geen gegevens	geen gegevens
Jingying Huang	Director of the Marketing Center	no data	geen gegevens	geen gegevens
Huadong Li	Chief Human Resources Officer	no data	geen gegevens	geen gegevens
Huabin Yang	Executive Director	less than a year	geen gegevens	geen gegevens
Yang Feng	Executive Director	less than a year	geen gegevens	geen gegevens
Yuen Ling Lam	Company Secretary	less than a year	geen gegevens	geen gegevens

0.8yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 2329 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Zhangsun Zhang	Chairman & President	no data	CN¥3.00m	76.71% HK$ 416.0m
Wenjuan Ruan	VP & Executive Director	no data	CN¥2.27m	geen gegevens
Zhenhe Hao	VP & Executive Director	3yrs	CN¥240.00k	geen gegevens
Yuhong Zhao	GM of the Operation & HR Mgmt Center	less than a year	geen gegevens	geen gegevens
Huabin Yang	Executive Director	less than a year	geen gegevens	geen gegevens
Yang Feng	Executive Director	less than a year	geen gegevens	geen gegevens
Jinrong Chen	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens
Zhidong Deng	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

0.8yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2329 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.

Glory Health Industry Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd